Marie Vetizou
Overview
Explore the profile of Marie Vetizou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
4355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demaria O, Habif G, Vetizou M, Gauthier L, Remark R, Chiossone L, et al.
Sci Immunol
. 2024 Nov;
9(101):eadp3720.
PMID: 39546590
NK cells offer a promising alternative to T cell therapies in cancer. We evaluated IPH6501, a clinical-stage, tetraspecific NK cell engager (NKCE) armed with a non-alpha IL-2 variant (IL-2v), which...
2.
Demaria O, Gauthier L, Vetizou M, Alvarez A, Vagne C, Habif G, et al.
Cell Rep Med
. 2022 Oct;
3(10):100783.
PMID: 36260981
Harnessing innate immunity is emerging as a promising therapeutic approach in cancer. We report here the design of tetraspecific molecules engaging natural killer (NK) cell-activating receptors NKp46 and CD16a, the...
3.
McCulloch J, Davar D, Rodrigues R, Badger J, Fang J, Cole A, et al.
Nat Med
. 2022 Mar;
28(3):545-556.
PMID: 35228752
Ample evidence indicates that the gut microbiome is a tumor-extrinsic factor associated with antitumor response to anti-programmed cell death protein-1 (PD-1) therapy, but inconsistencies exist between published microbial signatures associated...
4.
Spencer C, McQuade J, Gopalakrishnan V, McCulloch J, Vetizou M, Cogdill A, et al.
Science
. 2021 Dec;
374(6575):1632-1640.
PMID: 34941392
Gut bacteria modulate the response to immune checkpoint blockade (ICB) treatment in cancer, but the effect of diet and supplements on this interaction is not well studied. We assessed fecal...
5.
Davar D, Dzutsev A, McCulloch J, Rodrigues R, Chauvin J, Morrison R, et al.
Science
. 2021 Feb;
371(6529):595-602.
PMID: 33542131
Anti-programmed cell death protein 1 (PD-1) therapy provides long-term clinical benefits to patients with advanced melanoma. The composition of the gut microbiota correlates with anti-PD-1 efficacy in preclinical models and...
6.
Koyama M, Mukhopadhyay P, Schuster I, Henden A, Hulsdunker J, Varelias A, et al.
Immunity
. 2019 Sep;
51(5):885-898.e7.
PMID: 31542340
Graft-versus-host disease (GVHD) in the gastrointestinal (GI) tract is the principal determinant of lethality following allogeneic bone marrow transplantation (BMT). Here, we examined the mechanisms that initiate GVHD, including the...
7.
Kumar M, Singh P, Murugesan S, Vetizou M, McCulloch J, Badger J, et al.
Methods Mol Biol
. 2019 Sep;
2055:595-638.
PMID: 31502171
Humans are living ecosystems composed of human cells and microbes. The microbiome is the collection of microbes (microbiota) and their genes. Recent breakthroughs in the high-throughput sequencing technologies have made...
8.
Jacquelot N, Yamazaki T, Roberti M, Duong C, Andrews M, Verlingue L, et al.
Cell Res
. 2019 Sep;
29(10):846-861.
PMID: 31481761
PD-1 blockade represents a major therapeutic avenue in anticancer immunotherapy. Delineating mechanisms of secondary resistance to this strategy is increasingly important. Here, we identified the deleterious role of signaling via...
9.
Vetizou M, Trinchieri G
Cell Res
. 2018 Jan;
28(3):263-264.
PMID: 29336431
After the initial success of cancer immunotherapy using immune checkpoint blockers, the challenge is to understand why only a minority of patients respond to the therapy and to increase the...
10.
Vetizou M, Daillere R, Zitvogel L
Biol Aujourdhui
. 2017 Jul;
211(1):51-67.
PMID: 28682227
The gut microbiota is known to affect digestion, protection against pathogens infection, immune system maturation and enteric nervous system development, but others links have also been established with diabetes, obesity,...